Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
7.45
-0.37 (-4.73%)
Dec 20, 2024, 4:00 PM EST - Market closed
Phathom Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Net Income | -339.45 | -201.59 | -197.72 | -143.88 | -129.07 | -255.13 | Upgrade
|
| Depreciation & Amortization | 0.79 | 0.58 | 0.62 | 0.52 | 0.32 | 0.01 | Upgrade
|
| Other Amortization | 2.13 | 1.88 | 2.11 | 3.6 | 1.27 | 0.41 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 78.9 | Upgrade
|
| Stock-Based Compensation | 41.94 | 45.03 | 24.13 | 16.81 | 5.84 | 0.41 | Upgrade
|
| Other Operating Activities | 53.06 | 30.18 | 18.89 | 1.81 | 0.23 | 148.42 | Upgrade
|
| Change in Accounts Receivable | -21.05 | -1.64 | - | - | - | - | Upgrade
|
| Change in Inventory | -9.9 | -9.44 | - | - | - | - | Upgrade
|
| Change in Accounts Payable | 25.26 | 6.41 | 8.68 | -9.79 | 24.01 | 2.27 | Upgrade
|
| Change in Other Net Operating Assets | 0.1 | -8.98 | -3.24 | -17.52 | 27.71 | -11.79 | Upgrade
|
| Operating Cash Flow | -247.11 | -137.58 | -146.53 | -148.46 | -69.69 | -36.51 | Upgrade
|
| Capital Expenditures | -0.61 | -1.63 | -1.04 | -0.33 | -1.04 | -0.13 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | - | -25.12 | Upgrade
|
| Investing Cash Flow | -0.61 | -1.63 | -1.04 | -0.33 | -1.04 | -25.25 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 88.32 | Upgrade
|
| Long-Term Debt Issued | - | 211.99 | 95.45 | 96.89 | 25 | 24.85 | Upgrade
|
| Total Debt Issued | 246.64 | 211.99 | 95.45 | 96.89 | 25 | 113.17 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -54.13 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 246.64 | 211.99 | 95.45 | 42.76 | 25 | 113.17 | Upgrade
|
| Issuance of Common Stock | 122.08 | 155.59 | 24.6 | 1.94 | 89.46 | 191.47 | Upgrade
|
| Financing Cash Flow | 368.72 | 367.58 | 120.04 | 44.71 | 114.46 | 304.65 | Upgrade
|
| Net Cash Flow | 121.01 | 228.37 | -27.53 | -104.08 | 43.73 | 242.89 | Upgrade
|
| Free Cash Flow | -247.72 | -139.21 | -147.57 | -148.79 | -70.73 | -36.64 | Upgrade
|
| Free Cash Flow Margin | -942.96% | -20412.61% | - | - | - | - | Upgrade
|
| Free Cash Flow Per Share | -4.15 | -2.71 | -3.77 | -4.02 | -2.13 | -3.22 | Upgrade
|
| Cash Interest Paid | 15.39 | 11.13 | 7.03 | 4.07 | 3.46 | 1.01 | Upgrade
|
| Levered Free Cash Flow | -179.77 | -90.45 | -93.78 | -96.73 | -22.93 | -52.58 | Upgrade
|
| Unlevered Free Cash Flow | -140.37 | -66.1 | -78.83 | -96.08 | -21.34 | -50.37 | Upgrade
|
| Change in Net Working Capital | 2.55 | 5.5 | -5.24 | 28.66 | -52.07 | 8.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.